Who has invested in Acesion Pharma?

Canaan, Alpha Wave Global, Global BioAccess Fund, Novo Holdings are named among the investors backing Acesion Pharma.

Acesion Pharma Funding: $51M Raised, Series B (2023)

Acesion Pharma funding overview

Acesion Pharma is based in Copenhagen, Denmark. Acesion Pharma has raised $51M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2023. The round record for Acesion Pharma runs through 2023; nothing later has been disclosed. Investors on record include Canaan, Alpha Wave Global, Global BioAccess Fund, Novo Holdings. 4 distinct backers are named across the disclosed rounds.

Acesion Pharma at a glance

Total raised: $51M
Latest round: Series B
Latest round date: September 2023
Headquarters: Copenhagen, Denmark
Notable investors: Canaan, Alpha Wave Global, Global BioAccess Fund, Novo Holdings

Frequently asked about Acesion Pharma funding

How much has Acesion Pharma raised?: Acesion Pharma has raised $51M in total disclosed funding across the rounds on record.
Who has invested in Acesion Pharma?: Canaan, Alpha Wave Global, Global BioAccess Fund, Novo Holdings are named among the investors backing Acesion Pharma.
What was the latest Acesion Pharma funding round?: The most recent disclosed round is a Series B, announced in September 2023.
Where is Acesion Pharma based?: Acesion Pharma is based in Copenhagen, Denmark.
When did Acesion Pharma last raise?: The last disclosed Acesion Pharma round closed in September 2023 at Series B.

Round data for Acesion Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Copenhagen and backer lists below.

Acesion Pharma Funding: $51M Raised, Series B (2023)

Acesion Pharma funding overview

Acesion Pharma at a glance

Frequently asked about Acesion Pharma funding

Companies related to Acesion Pharma (36)

Browse related funding lists (6)